Financial Services

After solving a key manufacturing flaw, CervoMed advances its promising dementia drug, neflamapimod, to a Phase 3 trial with an optimized dose.

NBA champion Metta World Peace's AI likeness is selling products in Asia, pioneering an ethical model for celebrity monetization in a digital world.

An injured 'begging' elephant's rescue via a state-of-the-art ambulance highlights a new chapter in the fight against animal exploitation in India.

By integrating a key AI standard, the firm is positioning its trusted policy data as the foundational layer for AI agents from Google, OpenAI, and more.

As Monro executives prepare for a key investor chat, all eyes are on their strategy for a changing auto market, from store closures to the EV revolution.

With its lead drug for a rare blood cancer nearing European submission, Cellectar Biosciences advances its targeted radiotherapy platform on two fronts.

The water solutions giant unveiled ambitious new financial targets, aiming to capitalize on water scarcity and infrastructure needs while reassuring investors.

FDA approves Glenmark's generic inhaler with 180-day exclusivity, promising lower costs for millions and disrupting a major respiratory drug market.

A massive $125M investment empowers five international teams to pursue radical ideas, from cancer-proof people to self-destructing tumors.

The green builder secured its Nasdaq status, but a sharp stock drop reveals market skepticism. Can its $78.5M pipeline convince cautious investors?

A nonprofit's initiative just gave its 4 millionth free vaccine, revealing a strategic model that tackles pet health crises and opens doors to lifelong care.

A critical bird rookery in the Indian River Lagoon is saved from erosion by an innovative project, offering a blueprint for coastal resilience and hope.

Theolytics secures a prestigious €8 million EU grant to advance its unique cancer-killing virus, offering new hope for hard-to-treat ovarian cancer.

A major investment from All Seas Capital will fuel Sereni's rapid consolidation of Europe's fragmented funeral industry, signaling a new era of modernization.

As a deadly superbug spreads, BioVersys's BV100 enters late-stage trials, backed by promising data and a novel scientific approach to combat resistance.

The WPIC forecasts another major platinum deficit for 2026, signaling continued market tightness, price support, and a complex global supply struggle.

Amperity appoints veteran CMO Bridget Perry to lead its push as companies seek real ROI from AI, betting on her experience to scale its data cloud.

The biotech plans to separate its R&D pipeline from its booming royalty assets, creating two public companies and winning applause from Wall Street.

Immunome announces stellar Phase 3 data for its desmoid tumor drug, varegacestat, and details a robust, well-funded ADC pipeline aimed at solid tumors.

Younger buyers are treating timepieces as investments, fueling a boom that allows small online watch sellers to challenge legacy giants. Here's how.